192 related articles for article (PubMed ID: 2877420)
1. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
2. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
3. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.
Gaspar P; Duyckaerts C; Febvret A; Benoit R; Beck B; Berger B
Brain Res; 1989 Jun; 490(1):1-13. PubMed ID: 2569349
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.
Chan-Palay V
J Comp Neurol; 1987 Jun; 260(2):201-23. PubMed ID: 2886516
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-like immunoreactivity within neuritic plaques.
Armstrong DM; LeRoy S; Shields D; Terry RD
Brain Res; 1985 Jul; 338(1):71-9. PubMed ID: 2862952
[TBL] [Abstract][Full Text] [Related]
6. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques.
Unger JW; McNeill TH; Lapham LL; Hamill RW
Brain Res; 1988 Jun; 452(1-2):293-302. PubMed ID: 2900051
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin- and neuropeptide Y-immunoreactive cortical neurons in senile dementia of Alzheimer type].
Nakamura S; Akiguchi I; Kameyama M; Nakamura N; Kimura H
Nihon Ronen Igakkai Zasshi; 1986 Nov; 23(6):594-9. PubMed ID: 2882040
[No Abstract] [Full Text] [Related]
9. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.
Dawbarn D; Emson PC
Biochem Biophys Res Commun; 1985 Jan; 126(1):289-94. PubMed ID: 3838246
[TBL] [Abstract][Full Text] [Related]
13. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
14. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
Dawbarn D; De Quidt ME; Emson PC
Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Chattha GK; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Sep; 20(3):282-8. PubMed ID: 3767313
[TBL] [Abstract][Full Text] [Related]
16. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons.
Zhang ZJ; Lappi DA; Wrenn CC; Milner TA; Wiley RG
Brain Res; 1998 Aug; 800(2):198-206. PubMed ID: 9685641
[TBL] [Abstract][Full Text] [Related]
17. Morphology and distribution of neuropeptide-containing neurons in human cerebral cortex.
Hornung JP; De Tribolet N; Törk I
Neuroscience; 1992 Nov; 51(2):363-75. PubMed ID: 1281528
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration.
Minthon L; Edvinsson L; Ekman R; Gustafson L
J Neural Transm Suppl; 1990; 30():57-67. PubMed ID: 1975266
[TBL] [Abstract][Full Text] [Related]
19. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Leake A; Perry EK; Perry RH; Jabeen S; Fairbairn AF; McKeith IG; Ferrier IN
Biol Psychiatry; 1991 Feb; 29(4):357-64. PubMed ID: 1674664
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.
German DC; White CL; Sparkman DR
Neuroscience; 1987 May; 21(2):305-12. PubMed ID: 3302759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
